Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R6JV
|
||||
Former ID |
DIB000702
|
||||
Drug Name |
CX-1739
|
||||
Synonyms |
CX-1739 (injectable/AMPAKINE, respiratory depression); CX-717 follow-on compound (AMPAKINE), Cortex Pharmaceuticals; CX-1739 (injectable/AMPAKINE, respiratory depression), Biovail Laboratories; CX-1739 (injectable/AMPAKINE, respiratory depression), Cortex Pharmaceuticals; CX-1739 (injectable/AMPAKINE, respiratory depression), Valeant
|
||||
Indication | Attention deficit hyperactivity disorder [ICD9: 314; ICD10:F90] | Phase 2 | [548779] | ||
Company |
Cortex Pharmaceuticals Inc
|
||||
Target and Pathway | |||||
Target(s) | Glutamate receptor AMPA subtype | Target Info | Agonist | [531966] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.